BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen L. From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus. World J Hepatol 2023; 15(12): 1253-1257 [PMID: 38223415 DOI: 10.4254/wjh.v15.i12.1253]
URL: https://www.wjgnet.com/1948-5182/full/v15/i12/1253.htm
Number Citing Articles
1
Weixin Wang, Xin Gao, Wentong Niu, Jinping Yin, Kan He. Targeting Metabolism: Innovative Therapies for MASLD UnveiledInternational Journal of Molecular Sciences 2025; 26(9): 4077 doi: 10.3390/ijms26094077
2
Salvatore Corrao, Luigi Calvo, Walter Granà, Salvatore Scibetta, Luigi Mirarchi, Simona Amodeo, Fabio Falcone, Christiano Argano. Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the futureNutrition, Metabolism and Cardiovascular Diseases 2025; 35(2): 103702 doi: 10.1016/j.numecd.2024.07.019
3
Anil Chandra Anand, Dibyalochan Praharaj. MASLD or MAFLD: fatty liver by any name will pose the same challengeMetabolism and Target Organ Damage 2025; 5(2) doi: 10.20517/mtod.2025.18
4
Xiao-Xuan Tang, Rui Wu, Jun-Hui Chen, Feng-Lan Wang, Sai-Li Zhao, Jie Lu, Jian Qin, Duan-Ming Zhuang, Bin Zhang. Association between HOMA-IR and metabolic dysfunction-associated steatohepatitis in U.S. adults with MASLDMetabolism Open 2025; 28: 100402 doi: 10.1016/j.metop.2025.100402
5
Chun-Hui Shao, Vipul Wayal, Chang-Chi Hsieh. Goat Whey Protein Hydrolysate Mitigates High-Fructose Corn Syrup-Induced Hepatic Steatosis in a Murine ModelNutrients 2025; 17(12): 2011 doi: 10.3390/nu17122011
6
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya. Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A ReviewPreventive Medicine: Research & Reviews 2025; 2(4): 183 doi: 10.4103/PMRR.PMRR_159_24
7
Ilaria Milani, Michela Codini, Gloria Guarisco, Marianna Chinucci, Chiara Gaita, Frida Leonetti, Danila Capoccia. Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic TargetInternational Journal of Molecular Sciences 2024; 25(19): 10795 doi: 10.3390/ijms251910795
8
Ehsan Amini-Salehi, Negin Letafatkar, Naeim Norouzi, Farahnaz Joukar, Arman Habibi, Mona Javid, Nazila Sattari, Mehrdad Khorasani, Ali Farahmand, Shervin Tavakoli, Behnaz Masoumzadeh, Elaheh Abbaspour, Sahand Karimzad, Amir Ghadiri, Gautam Maddineni, Mohammad Javad Khosousi, Niloofar Faraji, Mohammad-Hossein Keivanlou, Abinash Mahapatro, Mohamad Amin Khajavi Gaskarei, Paria Okhovat, Ali Bahrampourian, Maryam Sadat Aleali, Arian Mirdamadi, Narges Eslami, Mohamadreza Javid, Naz Javaheri, Shrinidhi Vilas Pra, Arash Bakhsi, Mohammad Shafipour, Azin Vakilpour, Malek Moein Ansar, Sai Guatham Kanagala, Mohamad Hashemi, Arezoo Ghazalgoo, Masoumeh Kheirandish, Parham Porteghali, Forough Heidarzad, Taraneh Zeinali, Fariborz Mansour Ghanaei, Soheil Hassanipour, Michael.T Ulrich, Joshua E. Melson, Dhruvan Patel, Sandeep Samethadka Nayak. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 CountriesArchives of Medical Research 2024; 55(6): 103043 doi: 10.1016/j.arcmed.2024.103043
9
Khaled Naja, Najeha Anwardeen, Mohamed A. Elrayess. Metabolomic Signatures of MASLD Identified by the Fatty Liver Index Reveal Gamma-Glutamyl Cycle Disruption and Lipid RemodelingMetabolites 2025; 15(11): 687 doi: 10.3390/metabo15110687
10
Georgiana-Diana Cazac, Bogdan-Mircea Mihai, Gabriela Ștefănescu, Georgiana-Emmanuela Gîlcă-Blanariu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Cristina-Mihaela Lăcătușu. Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver DiseaseNutrients 2024; 16(13): 2008 doi: 10.3390/nu16132008
11
Qian Liu, Zuxi Gu, Xin Xin, Xiaoping Shen, Xiaojun Gou, Lixin Hou, Shuang Li. Qushi huayu decoction dose-dependent inhibition of caspase-2/SREBP-1 in MASLD miceHereditas 2025; 162(1) doi: 10.1186/s41065-025-00561-x
12
Dalia M. Miller, Kiana F. McCauley, Kimberly J. Dunham‐Snary. Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic AdvancesEndocrinology, Diabetes & Metabolism 2025; 8(6) doi: 10.1002/edm2.70132
13
Hai Zhao, Wei Fan, Yan Yan, Yuxing Liu, Xuejun Kang. The Associations of Serum Folate Forms with Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Fibrosis: A Nationwide Cross-Sectional StudyMetabolites 2025; 15(6): 370 doi: 10.3390/metabo15060370
14
Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Govind Pradeep, Aswathy R. Devan, Gautam Sethi, Lekshmi R. Nath. Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: Therapeutic insights and strategiesDrug Discovery Today 2024; 29(8): 104064 doi: 10.1016/j.drudis.2024.104064